Nature Index

From antibiotics and organoids to CRISPR, improved biomedical methods and apparatus are enabling new therapies.

Corporate research in the life sciences endures, despite diminishing in other fields of science.

This scientific partnership could fight everything from blood diseases to HIV.

Ethical and equity challenges become more urgent.

At the Estonian Genome Centre, the geneticist and her team are investigating the impact of genetic variations on drug metabolism and adherence to prescriptions.

The country hopes building connections with overseas researchers will help lift its research performance.

Insular institutions seek ways to better accommodate international research partners.

Academia and industry in Japan remain disconnected, despite efforts to bring them together.

Six scientists whose transformative work reaches across borders.

A description of the terminology and methodology used in this supplement, and a guide to the functionality available free online at natureindex.com

The vast gender gap in Japanese science has leading women researchers calling for change.

To become a world-leading scientific nation in every sense, China needs to close the quality gap.

China now publishes more scientific research than the United States, but on measures of quality, including publication of articles in the top-notch journals tracked by the Nature Index, it still falls short, with some notable subject exceptions.

The discipline’s historic prominence in China is underpinned by its crucial value to industrial processes. Committed funding sees it leading the way in emerging areas, such as nanomaterials.

A description of the terminology and methodology used in this supplement, and a guide to the functionality available free online at natureindex.com.

Studies to improve the productivity, resistance and taste of rice crops are central to China’s commanding position in plant biology.

China’s nanotech industry is forging ahead, with high funding levels, a maturing talent pool, and international experience.

Few Chinese researchers are regarded as global leaders, as the pressure for rapid output prevails.

A permissive regulatory climate and a pragmatic approach has seen China’s bioscience sector soar.

The increasing production of papers and a propensity to cite compatriots makes China likely to win the referencing race.